Does single application of topical chloramphenicol to high risk sutured wounds reduce incidence of wound infection after minor surgery? Prospective randomised placebo controlled double blind trial.
BMJ 2009;
338:a2812. [PMID:
19147639 PMCID:
PMC2628297 DOI:
10.1136/bmj.a2812]
[Citation(s) in RCA: 46] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
OBJECTIVE
To determine the effectiveness of a single application of topical chloramphenicol ointment in preventing wound infection after minor dermatological surgery.
DESIGN
Prospective randomised placebo controlled double blind multicentre trial.
SETTING
Primary care in a regional centre in Queensland, Australia.
PARTICIPANTS
972 minor surgery patients.
INTERVENTIONS
A single topical dose of chloramphenicol (n=488) or paraffin ointment (n=484; placebo).
MAIN OUTCOME MEASURE
Incidence of infection.
RESULTS
The incidence of infection in the chloramphenicol group (6.6%; 95% confidence interval 4.9 to 8.8) was significantly lower than that in the control group (11.0%; 7.9 to 15.1) (P=0.010). The absolute reduction in infection rate was 4.4%, the relative reduction was 40%, and the relative risk of wound infection in the control group was 1.7 (95% confidence interval 1.1 to 2.5) times higher than in the intervention group. The number needed to treat was 22.8.
CONCLUSION
Application of a single dose of topical chloramphenicol to high risk sutured wounds after minor surgery produces a moderate absolute reduction in infection rate that is statistically but not clinically significant. Trial registration Current Controlled Trials ISRCTN73223053.
Collapse